PINELABS vs SHUKRAPHAR: Stock Comparison
Head-to-head financial and trading comparison between Pine Labs Limited (PINELABS) and Shukra Pharmaceuticals Limited (SHUKRAPHAR) in the Cross-Sector Peers sector.
PINELABS
NSE: PINELABSSHUKRAPHAR
NSE: SHUKRAPHARKey Metrics Comparison Table
| Metric | PINELABS | SHUKRAPHAR | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹163.07 | ₹66.94 | — |
| 1-Year Price Return | -15.94% | +61.61% | SHUKRAPHAR (77.55% higher) |
| 52-Week High | ₹205.47 | ₹72.58 | — |
| 52-Week Low | ₹137.94 | ₹41.42 | — |
| 30-Day Annualized Volatility | 68.58% | 64.68% | SHUKRAPHAR (Steadier) |
| 30-Day Average Daily Volume | 39,650,606 | 6,592,919 | PINELABS (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between PINELABS and SHUKRAPHAR, which stock gave better returns over the last year?
SHUKRAPHAR has outperformed PINELABS over the past 12 months with a gain of 61.61% compared to -15.94%.
Which stock is less volatile: PINELABS or SHUKRAPHAR?
SHUKRAPHAR demonstrated lower price volatility (64.68% annualized) compared to PINELABS (68.58%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of PINELABS vs SHUKRAPHAR?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are PINELABS and SHUKRAPHAR direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.